Toggle navigation
Menu
Home
News
Local
National
World
Politics
Sports
Entertainment
Business
Health
News Tip Hotline
Weather
Bend
Traffic
Live Traffic Cams
Central Oregon
Mountain Passes
Road Reports
Trip Check
Gas Prices
Closures and Delays
Stations
KQAK-FM 105.7
The Peak 104.1
The Ranch 95.7 FM
KBNW-AM/FM
KRCO-AM
Events
Upcoming
Concerts
Submit An Event
Submit A PSA
Interviews
Inside Central Oregon
Central Oregon Spotlight
Water Wise Tips
HBG Interviews
Ray’s Random Questions
Just Used Cars as Heard on KQAK & The Ranch
About MCO
Contact/About Us
Advertise
Careers
Media Kit
Radio Stations
Contest Rules
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Legend Biotech Corporation - American Depositary Shares
(NQ:
LEGN
)
21.63
-0.67 (-3.00%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 30, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Legend Biotech Corporation - American Depositary Shares
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
AMD To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Friday
↗
October 17, 2025
Via
Benzinga
Johnson & Johnson Stock Falls Premarket: Investors Eye MedTech Growth, Tariff Impact And Drug Pipeline In Q3 Print
↗
October 14, 2025
Investors may also look for updates on J&J’s reported talks to acquire Protagonist Therapeutics to bolster its immunology and oncology pipeline.
Via
Stocktwits
Topics
Government
World Trade
Expert Outlook: Legend Biotech Through The Eyes Of 6 Analysts
↗
October 09, 2025
Via
Benzinga
Amgen Surges on Repatha Expansion, Manufacturing Boost, and Strong Earnings
October 02, 2025
Thousand Oaks, CA – October 2, 2025 – Amgen (NASDAQ: AMGN) has witnessed a robust surge in its share price, climbing approximately 6% in recent trading sessions, culminating on October 2, 2025, to...
Via
MarketMinute
Topics
Economy
Intellectual Property
Stocks
How Do Investors Really Feel About Legend Biotech?
↗
September 22, 2025
Via
Benzinga
Legend Biotech Considering Second Listing Outside US: Report
↗
September 05, 2025
Via
Stocktwits
How Do Investors Really Feel About Legend Biotech?
↗
September 04, 2025
Via
Benzinga
Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference
August 26, 2025
From
Legend Biotech USA Inc.
Via
GlobeNewswire
Legend Biotech Appoints Carlos Santos as Chief Financial Officer
August 18, 2025
From
Legend Biotech USA Inc.
Via
GlobeNewswire
The Analyst Verdict: Legend Biotech In The Eyes Of 5 Experts
↗
August 12, 2025
Via
Benzinga
Earnings Outlook For Legend Biotech
↗
August 08, 2025
Via
Benzinga
Looking Into Legend Biotech's Recent Short Interest
↗
July 17, 2025
Via
Benzinga
Is Legend Biotech Gaining or Losing Market Support?
↗
June 12, 2025
Via
Benzinga
Beyond the Headlines: A Look at Today's Key Corporate Earnings Reports
August 11, 2025
Today, August 11, 2025, marks a significant day for investors looking beyond the typical S&P 500 giants, as a diverse array of companies across various sectors unveiled their latest quarterly earnings....
Via
MarketMinute
Topics
Economy
Stocks
Legend Biotech Corp. (NASDAQ:LEGN) Reports Mixed Q2 2025 Earnings with Revenue Beat and EPS Miss Amid Strong CARVYKTI Sales
↗
August 11, 2025
Legend Biotech's Q2 2025 earnings show revenue beat at $255.1M, driven by strong CARVYKTI sales, but EPS missed at -$0.34. Stock rose 1.4% pre-market.
Via
Chartmill
Legend Biotech Reports Second Quarter 2025 Results and Recent Highlights
August 11, 2025
From
Legend Biotech USA Inc.
Via
GlobeNewswire
What Does the Market Think About Legend Biotech?
↗
April 29, 2025
Via
Benzinga
Earnings Scheduled For August 11, 2025
↗
August 11, 2025
Via
Benzinga
Legend Biotech to Host Investor Conference Call on Second Quarter 2025 Results
July 28, 2025
From
Legend Biotech USA Inc.
Via
GlobeNewswire
A Glimpse Into The Expert Outlook On Legend Biotech Through 6 Analysts
↗
July 02, 2025
Via
Benzinga
The FDA Shake-Up Continues, And Could Impact Genetic Medicines
↗
June 20, 2025
Nicole Verdun and Rachael Anatol were placed on administration leave without explanation.
Via
Investor's Business Daily
Topics
Government
Insmed, Tesla, Casey's General Stores And Other Big Stocks Moving Higher On Tuesday
↗
June 10, 2025
Via
Benzinga
Quanex Building Products, Manchester United, Byrna Technologies And Other Big Stocks Moving Higher On Friday
↗
June 06, 2025
Via
Benzinga
Legend Biotech Unveils Groundbreaking 5-Year Survival Data for CARVYKTI® in Multiple Myeloma at 2025 ASCO Annual Meeting
June 03, 2025
From
Legend Biotech USA Inc.
Via
GlobeNewswire
Legend Biotech Announces New Oncologic & Hematologic Therapeutic Developments at ASCO, EHA, and ASGCT
May 22, 2025
From
Legend Biotech USA Inc.
Via
GlobeNewswire
Legend Biotech to Host Investor Event During the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
May 19, 2025
From
Legend Biotech USA Inc.
Via
GlobeNewswire
Legend Biotech Reports First Quarter 2025 Results and Recent Highlights
May 13, 2025
From
Legend Biotech USA Inc.
Via
GlobeNewswire
Legend Biotech to Host Investor Conference Call on First Quarter 2025 Results
April 29, 2025
From
Legend Biotech USA Inc.
Via
GlobeNewswire
Earnings Scheduled For May 13, 2025
↗
May 13, 2025
Via
Benzinga
Netflix, Ericsson, Hewlett Packard Enterprise And Other Big Stocks Moving Higher On Monday
↗
April 15, 2025
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
581446795
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/60.0.3112.113 Safari/537.36
00fbf3724072e3a4c643b60a8db5a8756c4f8c05
1
